University of Oklahoma Health Sciences Center: Stephenson Cancer Center Researcher Leads Global Trial for Promising New Drug for Ovarian Cancer
January 20, 2024
January 20, 2024
OKLAHOMA CITY, Oklahoma, Jan. 20 (TNSres) -- The University of Oklahoma Health Sciences Center issued the following news:
Results of a global clinical trial published recently in The New England Journal of Medicine show that a new drug significantly improves survival in women with epithelial ovarian cancer, a deadly gynecologic cancer that often becomes resistant to chemotherapy. The lead author of the study is Kathleen Moore, M.D., associate director of clinical research at OU Heal . . .
Results of a global clinical trial published recently in The New England Journal of Medicine show that a new drug significantly improves survival in women with epithelial ovarian cancer, a deadly gynecologic cancer that often becomes resistant to chemotherapy. The lead author of the study is Kathleen Moore, M.D., associate director of clinical research at OU Heal . . .